Hysteroscopic myomectomy in a submucous fibroid 3 mm from the serosa: a case report

2006 ◽  
Vol 4 (2) ◽  
pp. 149-152 ◽  
Author(s):  
Ricardo Bassil Lasmar ◽  
Paulo Roberto Mussel Barrozo ◽  
Daniela Baltar da Rosa ◽  
Rogério Dias
2008 ◽  
Vol 6 (3) ◽  
pp. 283-286 ◽  
Author(s):  
Ricardo Bassil Lasmar ◽  
Paulo Roberto Mussel Barrozo ◽  
Daniela Baltar da Rosa ◽  
Bernardo Portugal Lasmar ◽  
Waldir P. Modotte ◽  
...  

2009 ◽  
Vol 57 (4) ◽  
pp. 535
Author(s):  
Jong Taek Park ◽  
Jae Chan Choi ◽  
Ji Yeon Lee ◽  
Dea Ja Um

Author(s):  
Thayane Delazari Corrêa ◽  
Isabela Maciel Caetano ◽  
Pedro Henrique Tannure Saraiva ◽  
Maurício Bechara Noviello ◽  
Admário Silva Santos Filho

Abstract Objective Gonadotropin-releasing hormone analogues (GnRH-a) have been used preoperatively before hysteroscopic myomectomy to decrease the size and vascularization of the myomas, but evidence to support this practice is weak. Our objective was to analyze the use of GnRH-a in the reduction of submucous fibroid as a facilitator for surgical hysteroscopy from published clinical trials. Data sources Studies from electronic databases (Pubmed, Scielo, EMBASE, Scopus, PROSPERO), published between 1980 and December 2018. The keywords used were fibroid, GnRH analogue, submucous, histeroscopy, histeroscopic resection and their correspondents in Portuguese. Study selection The inclusion criteria were controlled trials that evaluated the GnRH-a treatment before hysteroscopic resection of submucous myomas. Four clinical trials were included in the meta-analysis. Data collection Two review authors extracted the data without modification of the original data, using the agreed form. We resolved discrepancies through discussion or, if required, we consulted a third person. Data synthesis The present meta-analysis included a total of 213 women and showed no statistically significant differences in the use of GnRH-a compared with the control group for complete resection of submucous myoma (relative risk [RR]: 0.94; 95% confidence interval [CI]: 0.80–1.11); operative time (mean difference [MD]: - 3.81; 95%CI : - 3.81–2.13); fluid absorption (MD: - 65.90; 95%CI: - 9.75–2.13); or complications (RR 0.92; 95%CI: 0.18–4.82). Conclusion The present review did not support the routine preoperative use of GnRH-a prior to hysteroscopic myomectomy. However, it is not possible to determine its inferiority when compared with the other methods due to the heterogeneity of existing studies and the small sample size.


2020 ◽  
Vol 36 (2) ◽  
pp. 322-326
Author(s):  
Kaoru Fukui ◽  
Hiromi Ugaki ◽  
Reisa Kakubari ◽  
Kentaro Kuritani ◽  
Yukari Miyoshi ◽  
...  

2009 ◽  
Vol 57 (5) ◽  
pp. 629 ◽  
Author(s):  
Hwan-Hee Kim ◽  
Jin-Young Hwang ◽  
Young-Tae Jeon ◽  
Jung-Won Hwang ◽  
Sang-Hwan Do ◽  
...  

2011 ◽  
Vol 27 (2) ◽  
pp. 425-428
Author(s):  
Eiji Koike ◽  
Yasushi Kotani ◽  
Masahiko Umemoto ◽  
Takako Tobiume ◽  
Ayako Miyazaki ◽  
...  

2009 ◽  
Vol 24 (2) ◽  
pp. 102
Author(s):  
Si Young Ok ◽  
Seung Hwa Ryoo ◽  
Young Hee Baek ◽  
Sang Ho Kim

2012 ◽  
Vol 10 (3) ◽  
pp. 242-243 ◽  
Author(s):  
A Thakur ◽  
A Agrawal ◽  
P Basnet ◽  
DK Uprety

Nonpuerperal uterine inversion is a rare condition. We describe a case report of chronic inversion secondary to submucous fibroid. A 37 years lady presented with acute retention of urine with submucous fibroid. Diagnosis of partial inversion was made intra operatively and she underwent abdominal hysterectomy. Health Renaissance; September-December 2012; Vol 10 (No.3);242-2431DOI: http://dx.doi.org/10.3126/hren.v10i3.7055


Sign in / Sign up

Export Citation Format

Share Document